On January 3rd iBIO president & CEO, John Conrad, joined his biosciences colleagues from across the country to ring the closing bell at the New York Stock Exchange (NYSE). And to talk about the industry in 2024 and the amazing growth of our life sciences industry in Illinois.
Special thank you to Jennifer Hawks Bland and NewYorkBIO for coordinating this group of leaders at the epicenter of the world’s financial sector, and providing us the opportunity to recognize the national collaboration it takes to drive innovation and improve patients quality of life.